FMP
Halozyme Therapeutics, Inc.
HALO
NASDAQ
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.
62.27 USD
1.21 (1.94%)
2024 Q4
2024 Q3
2024 Q2
2024 Q1
298.01M
290.08M
231.35M
195.88M
42.05M
49.43M
57.37M
46.09M
255.95M
240.66M
173.98M
149.79M
80.45M
77.46M
56.75M
54.24M
20.44M
18.46M
21.04M
19.11M
42.25M
41.24M
35.71M
35.13M
0
0
0
0
0
0
0
0
17.76M
17.76M
17.76M
17.76M
175.5M
163.2M
117.23M
95.54M
2.71M
1.95M
508k
486k
178.21M
165.15M
117.74M
96.03M
41.2M
28.14M
24.5M
19.2M
137.01M
137.01M
93.25M
76.82M
1.08
1.08
0.73
0.61
1.06
1.05
0.72
0.6
126.41M
126.85M
127.12M
126.94M
128.98M
130.13M
129.22M
128.89M
203.17M
190.03M
137.6M
115.75M
All figures are in USD.